| Literature DB >> 35746935 |
Katharine G Marder1, Tracy Barbour1, Stephen Ferber1, Olanike Idowu1, Amanda Itzkoff1.
Abstract
Transcranial magnetic stimulation (TMS) is an increasingly popular noninvasive brain stimulation modality. In TMS, a pulsed magnetic field is used to noninvasively stimulate a targeted brain region. Repeated stimulation produces lasting changes in brain activity via mechanisms of synaptic plasticity similar to long-term potentiation. Local application of TMS alters activity in distant, functionally connected brain regions, indicating that TMS modulates activity of cortical networks. TMS has been approved by the U.S. Food and Drug Administration for the treatment of major depressive disorder, obsessive-compulsive disorder, and smoking cessation, and a growing evidence base supports its efficacy in the treatment of other neuropsychiatric conditions. TMS is rapidly becoming part of the standard of care for treatment-resistant depression, where it yields response rates of 40%-60%. TMS is generally safe and well tolerated; its most serious risk is seizure, which occurs very rarely. This review aims to familiarize practicing psychiatrists with basic principles of TMS, including target localization, commonly used treatment protocols and their outcomes, and safety and tolerability. Practical considerations, including evaluation and monitoring of patients undergoing TMS, device selection, treatment setting, and insurance reimbursement, are also reviewed.Entities:
Keywords: Repetitive transcranial magnetic stimulation; Transcranial magnetic stimulation; major depressive disorder; obsessive-compulsive disorder; smoking cessation
Year: 2022 PMID: 35746935 PMCID: PMC9063593 DOI: 10.1176/appi.focus.20210021
Source DB: PubMed Journal: Focus (Am Psychiatr Publ) ISSN: 1541-4094